ASHPOfficial

How do we prioritize what goes where and to who when we don’t have enough to go around?  We welcome back  Dr. Ken Richman, Professor of Philosophy and Health Care Ethics and IRB Chair at MCPHS University to talk about how ethics play an important role when it comes to the fair distribution of scarce life-saving resources.

Join nationally recognized drug shortage expert Erin R. Fox, Pharm.D., BCPS, FASHP, Michael Ganio, Senior Director, Pharmacy Practice and Quality, and Tom Kraus, Vice President of Government Relations, as they discuss recent updates on drug shortages related to COVID-19 and the impact the recent federal relief law will have on managing the supply chain. 

Today we talk with Susan Goodin, Head of Pharmacy Practice, Patient and Investigator Engagement, and the Innovation Strategy Lead in Biotherapeutics Development for Janssen Research and Development.  Our focus is to talk about her experiences during her 25-year career while at the Rutgers Cancer Institute of New Jersey in managing drug shortages and discussing ethical considerations in prioritizing care and lessons learned from the oncology perspective. 

In today’s episode of ASHPOfficial, host Tom Kraus, Vice President, Office of Government Relations at ASHP interviews Kathryn DiBitetto, vice president of the government relations team at 340B Health. 340B Health is a nonprofit organization of more than 1,400 hospitals and health systems that participate in the 340B Drug Pricing Program. Kathryn strives to educate policymakers about the program, and, today, speaks directly to listeners about ways they can advocate for 340B.

----

COVID-19

Dr. Eric Maroyka, Pharm.D., BCPS, Senior Director, Center on Pharmacy Practice Advancement sits down with Dr. Ryan Roux, Pharm.D., M.S., Vice President of Pharmacy at The University of Texas MD Anderson Cancer Center to discuss COVID-19 preparation, response, and mitigation lessons learned to share with the field.

In this third installment of the series, Dr. Roux discusses lessons learned and key planning considerations for hospital and health-system pharmacy leaders with respect to pandemic planning, response, and mitigation. The coronavirus pandemic is stressing our healthcare system infrastructure, has the potential for a devastating economic fallout, and will test the outer limits of healthcare worker resilience. The potential and actual surge in COVID-19 patients is threatening the capability and capacity of the US healthcare system as well as the safety and welfare of healthcare workers.